Finally, pharmacologic inhibition of phosphorylated eIF4E reduced MDSC abundance and immunosuppressive function, and synergized with anti-PD-1 immunotherapy to delay tumor growth and metastasis [75]. Here, EIF4E is linked to neoplasm.